XOMA Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pr…
Biotechnology
US, EmeryVille [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about XOMA Corporation's gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | -7.1300 | -10.767 | 18 | 11 | -38 | -123 | -32 | -2 | -111 | -2 | 19 | 25 |
| 2016 | -3.5000 | -7.020 | 55 | 5 | -20 | -80 | -15 | -1 | -56 | -1 | 20 | 13 |
| 2017 | -8.8900 | 0.573 | 5 | 50 | -53 | 6 | -48 | -11 | -58 | -12 | 18 | 115 |
| 2018 | 0.7500 | -1.727 | 52 | 4 | 14 | -19 | 20 | -1 | 12 | -1 | 24 | 10 |
| 2019 | -1.5900 | -0.210 | 5 | 21 | -13 | -2 | -12 | -4 | -16 | -5 | 18 | 48 |
| 2020 | -0.8800 | 0.223 | 18 | 19 | -7 | 2 | 1 | -4 | -5 | -4 | 21 | 43 |
| 2021 | 1.2500 | 1.020 | 29 | 37 | 13 | 11 | 13 | -8 | 12 | -9 | 16 | 85 |
| 2022 | 1.4000 | -1.965 | 38 | 5 | 15 | -29 | 16 | -32 | 17 | -29 | 20 | 12 |
| 2023 | -1.5000 | -2.050 | 6 | 6 | -17 | -46 | -16 | -37 | -17 | -34 | 23 | 14 |
| 2024 | -4.0400 | -1.120 | 4 | 28 | -40 | -12 | -39 | -5 | -41 | -6 | 25 | 65 |
| 2025 | - | -0.550 | - | 36 | - | -6 | - | -7 | - | -8 | - | 83 |
| 2026 | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F11X/td> | - | 2.F111/td> | - | 2.F111 | - | 2.F111 |
| 2027 | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
| 2028 | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |